Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Dev Cell ; 58(22): 2597-2613.e4, 2023 Nov 20.
Artículo en Inglés | MEDLINE | ID: mdl-37673063

RESUMEN

An instructive role for metabolism in embryonic patterning is emerging, although a role for mitochondria is poorly defined. We demonstrate that mitochondrial oxidative metabolism establishes the embryonic patterning center, the Spemann-Mangold Organizer, via hypoxia-inducible factor 1α (Hif-1α) in Xenopus. Hypoxia or decoupling ATP production from oxygen consumption expands the Organizer by activating Hif-1α. In addition, oxygen consumption is 20% higher in the Organizer than in the ventral mesoderm, indicating an elevation in mitochondrial respiration. To reconcile increased mitochondrial respiration with activation of Hif-1α, we discovered that the "free" c-subunit ring of the F1Fo ATP synthase creates an inner mitochondrial membrane leak, which decouples ATP production from respiration at the Organizer, driving Hif-1α activation there. Overexpression of either the c-subunit or Hif-1α is sufficient to induce Organizer cell fates even when ß-catenin is inhibited. We propose that mitochondrial leak metabolism could be a general mechanism for activating Hif-1α and Wnt signaling.


Asunto(s)
Subunidad alfa del Factor 1 Inducible por Hipoxia , Mitocondrias , Organizadores Embrionarios , Animales , Adenosina Trifosfato/metabolismo , Hipoxia , Mitocondrias/metabolismo , Organizadores Embrionarios/metabolismo , Xenopus laevis
2.
J Clin Invest ; 125(4): 1433-45, 2015 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25798616

RESUMEN

Oxidative stress contributes to the loss of neurons in many disease conditions as well as during normal aging; however, small-molecule agents that reduce oxidation have not been successful in preventing neurodegeneration. Moreover, even if an efficacious systemic reduction of reactive oxygen and/or nitrogen species (ROS/NOS) could be achieved, detrimental side effects are likely, as these molecules regulate normal physiological processes. A more effective and targeted approach might be to augment the endogenous antioxidant defense mechanism only in the cells that suffer from oxidation. Here, we created several adeno-associated virus (AAV) vectors to deliver genes that combat oxidation. These vectors encode the transcription factors NRF2 and/or PGC1a, which regulate hundreds of genes that combat oxidation and other forms of stress, or enzymes such as superoxide dismutase 2 (SOD2) and catalase, which directly detoxify ROS. We tested the effectiveness of this approach in 3 models of photoreceptor degeneration and in a nerve crush model. AAV-mediated delivery of NRF2 was more effective than SOD2 and catalase, while expression of PGC1a accelerated photoreceptor death. Since the NRF2-mediated neuroprotective effects extended to photoreceptors and retinal ganglion cells, which are 2 very different types of neurons, these results suggest that this targeted approach may be broadly applicable to many diseases in which cells suffer from oxidative damage.


Asunto(s)
Terapia Genética , Vectores Genéticos/uso terapéutico , Factor 2 Relacionado con NF-E2/uso terapéutico , Neuronas/fisiología , Traumatismos del Nervio Óptico/terapia , Estrés Oxidativo/fisiología , Retinitis Pigmentosa/terapia , Animales , Apoptosis , Catalasa/fisiología , Catalasa/uso terapéutico , Dependovirus/genética , Vectores Genéticos/genética , Ratones , Ratones Endogámicos C57BL , Ratones Mutantes , Factor 2 Relacionado con NF-E2/genética , Factor 2 Relacionado con NF-E2/fisiología , Compresión Nerviosa , Degeneración Nerviosa , Traumatismos del Nervio Óptico/fisiopatología , Coactivador 1-alfa del Receptor Activado por Proliferadores de Peroxisomas gamma , Células Fotorreceptoras Retinianas Conos/fisiología , Células Ganglionares de la Retina/fisiología , Superóxido Dismutasa/fisiología , Superóxido Dismutasa/uso terapéutico , Factores de Transcripción/fisiología , Factores de Transcripción/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA